Literature DB >> 9824512

Increased interleukin-1alpha and interleukin-1beta production by macrophages of low-density lipoprotein receptor knock-out mice stimulated with lipopolysaccharide is CD11c/CD18-receptor mediated.

M G Netea1, P N Demacker, B J Kullberg, O C Boerman, I Verschueren, A F Stalenhoef, J W Van Der Meer.   

Abstract

Immune mechanisms, including production of pro-inflammatory cytokines such as interleukin-1 (IL-1) and tumour necrosis factor (TNF), play an important role in early atherogenesis. The study of the mechanisms responsible for the increased cytokine production capacity of hypercholesterolemic hosts is therefore crucial for finding new strategies aimed to stop the development of atherosclerosis. We assessed the lipopolysaccharide (LPS)-induced cytokine production of macrophages from low-density lipoproteins (LDL)-receptor knock-out (LDLR-/-) mice, which have a seven- to ninefold higher plasma LDL concentration. Macrophages of LDLR-/- mice produced approximately twofold more IL-1alpha and IL-1beta in response to LPS when compared with macrophages of control mice (LDLR+/+). TNF-alpha synthesis was only slightly increased. Removal of CD14 by phospholipase C treatment of cells decreased cytokine production by 50% (IL-1) to 80% (TNF), but the differences between LDLR-/- and LDLR+/+ remained the same. In contrast, treatment of cells with anti-CD11c monoclonal antibody inhibited the IL-1alpha and IL-1beta production in LDLR-/- mice towards normal values, while no effect could be seen on TNF. In conclusion, LDLR-/- macrophages stimulated with LPS synthesize more IL-1alpha and IL-1beta than controls and this phenomenon is mediated by the CD11c/CD18 receptor.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9824512      PMCID: PMC1364415          DOI: 10.1046/j.1365-2567.1998.00598.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  30 in total

1.  Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction.

Authors:  P Saikku; M Leinonen; K Mattila; M R Ekman; M S Nieminen; P H Mäkelä; J K Huttunen; V Valtonen
Journal:  Lancet       Date:  1988-10-29       Impact factor: 79.321

2.  Distortion of endothelial repair. The effect of hypercholesterolaemia on regeneration of aortic endothelium following injury by endotoxin. A scanning electron microscope study.

Authors:  M A Reidy; D E Bowyer
Journal:  Atherosclerosis       Date:  1978-04       Impact factor: 5.162

3.  Induction of cell-associated interleukin 1 through stimulation of the adhesion-promoting proteins LFA-1 (CD11a/CD18) and CR3 (CD11b/CD18) of human monocytes.

Authors:  C Couturier; N Haeffner-Cavaillon; L Weiss; E Fischer; M D Kazatchkine
Journal:  Eur J Immunol       Date:  1990-05       Impact factor: 5.532

4.  Phagocyte function in familial hypercholesterolaemia: peripheral blood monocytes exposed to lipopolysaccharide show increased tumour necrosis factor production.

Authors:  M Leirisalo-Repo; M Jäättelä; H Gylling; T A Miettinen; H Repo
Journal:  Scand J Immunol       Date:  1990-12       Impact factor: 3.487

5.  Cholesterol regulates the cell surface expression of glycophospholipid-anchored CD14 antigen on human monocytes.

Authors:  M Esfahani; R D Bigler; J L Alfieri; S Lund-Katz; J D Baum; L Scerbo
Journal:  Biochim Biophys Acta       Date:  1993-07-04

6.  Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes.

Authors:  D Heumann; P Gallay; C Barras; P Zaech; R J Ulevitch; P S Tobias; M P Glauser; J D Baumgartner
Journal:  J Immunol       Date:  1992-06-01       Impact factor: 5.422

7.  Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study.

Authors:  P Saikku; M Leinonen; L Tenkanen; E Linnanmäki; M R Ekman; V Manninen; M Mänttäri; M H Frick; J K Huttunen
Journal:  Ann Intern Med       Date:  1992-02-15       Impact factor: 25.391

8.  Lipopolysaccharide-induced production of tumour necrosis factor and interleukin-1 is differentially regulated at the receptor level: the role of CD14-dependent and CD14-independent pathways.

Authors:  M G Netea; B J Kullberg; J W van der Meer
Journal:  Immunology       Date:  1998-07       Impact factor: 7.397

9.  Human phagocytes have multiple lipid A-binding sites.

Authors:  D T Golenbock; R Y Hampton; C R Raetz; S D Wright
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

10.  Cholesterol controls the clustering of the glycophospholipid-anchored membrane receptor for 5-methyltetrahydrofolate.

Authors:  K G Rothberg; Y S Ying; B A Kamen; R G Anderson
Journal:  J Cell Biol       Date:  1990-12       Impact factor: 10.539

View more
  5 in total

1.  More than inflammation: interleukin-1beta polymorphisms and the lipid metabolism.

Authors:  Mihai G Netea; Charles A Dinarello
Journal:  J Clin Endocrinol Metab       Date:  2011-05       Impact factor: 5.958

2.  Thiol oxidative stress induced by metabolic disorders amplifies macrophage chemotactic responses and accelerates atherogenesis and kidney injury in LDL receptor-deficient mice.

Authors:  Mu Qiao; Qingwei Zhao; Chi Fung Lee; Lisa R Tannock; Eric J Smart; Richard G LeBaron; Clyde F Phelix; Yolanda Rangel; Reto Asmis
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-07-10       Impact factor: 8.311

3.  IL-33 promotes eosinophilia in vivo and antagonizes IL-5-dependent eosinophil hematopoiesis ex vivo.

Authors:  Kimberly D Dyer; Caroline M Percopo; Helene F Rosenberg
Journal:  Immunol Lett       Date:  2012-12-11       Impact factor: 3.685

4.  Interferon Regulatory Factor 5 Controls Necrotic Core Formation in Atherosclerotic Lesions by Impairing Efferocytosis.

Authors:  Anusha N Seneviratne; Andreas Edsfeldt; Jennifer E Cole; Christina Kassiteridi; Maarten Swart; Inhye Park; Patricia Green; Tariq Khoyratty; David Saliba; Michael E Goddard; Stephen N Sansom; Isabel Goncalves; Rob Krams; Irina A Udalova; Claudia Monaco
Journal:  Circulation       Date:  2017-07-11       Impact factor: 29.690

Review 5.  Dynamic Macrophages: Understanding Mechanisms of Activation as Guide to Therapy for Atherosclerotic Vascular Disease.

Authors:  Julius L Decano; Masanori Aikawa
Journal:  Front Cardiovasc Med       Date:  2018-08-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.